Skip to content

Tropisetron

ALIMENTARY TRACT AND METABOLISM

Also known as: navoban, tropisetron HCl, tropisetron hydrochloride

YEAR INTRODUCED approvedATC A04AA03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tropisetron is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1992. DrugCentral lists 21 molecular targets, including Htr3a|Htr3b, HTR3B and HTR3A. Recorded indications include Chemotherapy-induced nausea and vomiting.

  • Molecular targets: Htr3a|Htr3b, HTR3B, HTR3A and Htr3a|Htr3b (21 listed in DrugCentral).
  • Indications: Chemotherapy-induced nausea and vomiting.
  • ATC code: A04AA03 (Serotonin (5HT3) antagonists).
  • Molecular formula: C17H20N2O2; molecular weight 284.36 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Chemotherapy-induced nausea and vomiting

Mechanism & targets

Molecular targets (21)

TargetGeneActionActivity
Serotonin 3 (5-HT3) receptorHtr3a|Htr3bunknownKi 8.89
5-hydroxytryptamine receptor 3BHTR3BunknownKi 8.80
5-hydroxytryptamine receptor 3AHTR3AantagonistKi 8.80
Serotonin 3 receptor (5HT3)Htr3a|Htr3bunknownKi 8.42
5-hydroxytryptamine receptor 1AHTR1AunknownKi 8.28
Neuronal acetylcholine receptor subunit alpha-7CHRNA7unknownKi 8.16
Neuronal acetylcholine receptor subunit alpha-7Chrna7unknownKi 8.16
Neuronal acetylcholine receptor subunit alpha-7Chrna7unknownEC50 8.00
5-hydroxytryptamine receptor 3AHTR3AunknownKd 7.52
5-hydroxytryptamine receptor 4Htr4unknownKi 7.20
5-hydroxytryptamine receptor 4Htr4antagonistKi 7.10
5-hydroxytryptamine receptor 4HTR4unknownKi 6.90
5-hydroxytryptamine receptor 4HTR4unknownKi 6.85
Sodium-dependent serotonin transporterSLC6A4unknownKi 6.59
Muscarinic acetylcholine receptor M5CHRM5unknownKi 5.61
Glycine receptor subunit betaGLRBantagonistKi 5.30
Glycine receptor subunit alpha-2GLRA2antagonistKi 4.90
Neuronal acetylcholine receptor subunit alpha-3CHRNA3unknownKi 4.80
Acetylcholine receptor; alpha1/beta1/delta/gammaCHRNA1|CHRNG|CHRNB1|CHRNDunknownKi 4.57
Neuronal acetylcholine receptor; alpha4/beta2CHRNB2|CHRNA4unknownKi 4.26

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1992-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
A04AA03ALIMENTARY TRACT AND METABOLISM › ANTIEMETICS AND ANTINAUSEANTS › ANTIEMETICS AND ANTINAUSEANTS › Serotonin (5HT3) antagonists

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Myelosuppression217.6
White blood cell count decreased205.6
Neutrophil count decreased176.3
Platelet count decreased169.5
Bone marrow failure149.6
Lymphocyte count decreased81.7
Hepatic function abnormal72.9
Vomiting68.1
Hypokalaemia64.5
Hepatotoxicity59.8
Hypocalcaemia55.7
Nausea53.1

Chemical structure

Molecular formulaC17H20N2O2
Molecular weight284.36 g/mol
CAS number89565-68-4
InChIKeyZNRGQMMCGHDTEI-ITGUQSILSA-N
PubChem CID656665
CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tropisetron used for?

DrugCentral lists the following indications for Tropisetron: Chemotherapy-induced nausea and vomiting.

How does Tropisetron work?

Its molecular targets in DrugCentral include Htr3a|Htr3b, HTR3B, HTR3A (antagonist) and Htr3a|Htr3b.

When was Tropisetron first approved?

Tropisetron was first approved by the YEAR INTRODUCED in 1992.

What is the chemical formula of Tropisetron?

Tropisetron has the molecular formula C17H20N2O2 and a molecular weight of 284.36 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1992-01-01
AgencyYEAR INTRODUCED
Targets21
Indications1
FormulaC17H20N2O2
DrugCentral ID2775
Interactive profile